Pub Date : 2026-01-09DOI: 10.1016/j.cireng.2026.800279
Marcos Bruna, María Asunción Acosta, Silvia Carbonell, Luis Gómez, Marian Mayo, Salvador Morales-Conde, Aitana Garcia-Tejero, Silvia Aguas, David Ruíz de Angulo, Vicente Munitiz, Luisa Martínez de Haro, Vanessa Concepción, Fernando Mingol, Miriam Menéndez, Gabriel Salcedo, Esteban Martín, Ana Senent, Alexis Luna, Dulce Momblán, Pablo Priego, María Posada, Purificación Parada, Rocío Pérez, Felipe Parreño, Coro Miranda, Carlos Loureiro, Lourdes Sanz, Mónica Miró
Hiatus hernia (HH) is a relatively prevalent condition in our setting, yet there is little clinical evidence or guidelines establishing precise recommendations for its diagnostic and therapeutic management. In order to establish clinical recommendations for the diagnostic and therapeutic management of patients with complex hiatal hernia, defined as a primary type III or IV mixed hernia, a large one with >30% of the gastric contents in the thoracic cavity, or a recurrence. This document was prepared based on current scientific evidence and the experience of a group of 28 expert surgeons, using GRADE methodology in order to establish recommendations on 13 controversial aspects related to this pathology. Although the quality of evidence and the degree of recommendation are high in some areas, high-quality prospective clinical studies are needed to clarify certain unresolved points of controversy.
{"title":"Complex hiatus hernias. Diagnostic and therapeutic management recommendations.","authors":"Marcos Bruna, María Asunción Acosta, Silvia Carbonell, Luis Gómez, Marian Mayo, Salvador Morales-Conde, Aitana Garcia-Tejero, Silvia Aguas, David Ruíz de Angulo, Vicente Munitiz, Luisa Martínez de Haro, Vanessa Concepción, Fernando Mingol, Miriam Menéndez, Gabriel Salcedo, Esteban Martín, Ana Senent, Alexis Luna, Dulce Momblán, Pablo Priego, María Posada, Purificación Parada, Rocío Pérez, Felipe Parreño, Coro Miranda, Carlos Loureiro, Lourdes Sanz, Mónica Miró","doi":"10.1016/j.cireng.2026.800279","DOIUrl":"10.1016/j.cireng.2026.800279","url":null,"abstract":"<p><p>Hiatus hernia (HH) is a relatively prevalent condition in our setting, yet there is little clinical evidence or guidelines establishing precise recommendations for its diagnostic and therapeutic management. In order to establish clinical recommendations for the diagnostic and therapeutic management of patients with complex hiatal hernia, defined as a primary type III or IV mixed hernia, a large one with >30% of the gastric contents in the thoracic cavity, or a recurrence. This document was prepared based on current scientific evidence and the experience of a group of 28 expert surgeons, using GRADE methodology in order to establish recommendations on 13 controversial aspects related to this pathology. Although the quality of evidence and the degree of recommendation are high in some areas, high-quality prospective clinical studies are needed to clarify certain unresolved points of controversy.</p>","PeriodicalId":93935,"journal":{"name":"Cirugia espanola","volume":" ","pages":"800279"},"PeriodicalIF":0.0,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145953657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-08DOI: 10.1016/j.cireng.2026.800275
Jordi Seguí Orejuela, Juan Jesús Rubio, Celia Villodre, María Marco, José M Ramia
{"title":"Pseudoaneurysm of the cystic artery: a rare complication.","authors":"Jordi Seguí Orejuela, Juan Jesús Rubio, Celia Villodre, María Marco, José M Ramia","doi":"10.1016/j.cireng.2026.800275","DOIUrl":"https://doi.org/10.1016/j.cireng.2026.800275","url":null,"abstract":"","PeriodicalId":93935,"journal":{"name":"Cirugia espanola","volume":" ","pages":"800275"},"PeriodicalIF":0.0,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145949527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-08DOI: 10.1016/j.cireng.2026.800277
Antonio Ríos, Beatriz Mahíllo, Beatriz Domínguez-Gil
The transmission of diseases through organ transplantation is an inherent risk to the transfer of biological material between individuals. This risk must be minimised, while also avoiding the unnecessary loss of organs suitable for transplantation obtained from donors with a history of a condition that may affect organ function or may be transmitted to the recipient-such donors are referred to as non-standard risk donors. The final decision to transplant organs from these donors must be made following a thorough risk/benefit assessment. To this end, the approach in Spain has been based on the provision of targeted support to transplant teams through the development and adoption of reference documents, a second-opinion system, and the generation of evidence through the prospective follow-up of recipients of organs transplanted from this type of donors.
{"title":"DEFINING SAFETY LIMITS IN ORGAN DONATION: THE NON-STANDARD RISK DONOR.","authors":"Antonio Ríos, Beatriz Mahíllo, Beatriz Domínguez-Gil","doi":"10.1016/j.cireng.2026.800277","DOIUrl":"https://doi.org/10.1016/j.cireng.2026.800277","url":null,"abstract":"<p><p>The transmission of diseases through organ transplantation is an inherent risk to the transfer of biological material between individuals. This risk must be minimised, while also avoiding the unnecessary loss of organs suitable for transplantation obtained from donors with a history of a condition that may affect organ function or may be transmitted to the recipient-such donors are referred to as non-standard risk donors. The final decision to transplant organs from these donors must be made following a thorough risk/benefit assessment. To this end, the approach in Spain has been based on the provision of targeted support to transplant teams through the development and adoption of reference documents, a second-opinion system, and the generation of evidence through the prospective follow-up of recipients of organs transplanted from this type of donors.</p>","PeriodicalId":93935,"journal":{"name":"Cirugia espanola","volume":" ","pages":"800277"},"PeriodicalIF":0.0,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145949524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-08DOI: 10.1016/j.cireng.2026.800276
Ismael Gómez Giménez, Juan Jesús Rubio Garcia, Silvia Carbonell Morote, José Manuel Ramia Ángel
Gastric cancer (GC) has high mortality due to late diagnosis from nonspecific symptoms. Advances in diagnostics and artificial intelligence (AI) promise earlier detection through greater sensitivity and specificity. This study reviews literature, including meta-analyses and systematic reviews, on AI in gastric adenocarcinoma (GA). In December 2024, following PRISMA, we searched PubMed, Web of Science, and Cochrane. Seventeen of 228 articles met inclusion criteria, comparing AI with other diagnostic or therapeutic approaches. Findings indicate AI may enhance imaging, histological assessment, endoscopy techniques, and surgical procedures. Progressive hospital implementation could significantly transform GA diagnosis, treatment, and prognosis.
胃癌(GC)由于非特异性症状诊断较晚,死亡率高。诊断技术和人工智能(AI)的进步有望通过提高灵敏度和特异性,更早地发现疾病。本研究回顾了有关AI在胃腺癌(GA)中的应用的文献,包括meta分析和系统综述。2024年12月,在PRISMA之后,我们搜索了PubMed、Web of Science和Cochrane。228篇文章中有17篇符合纳入标准,将人工智能与其他诊断或治疗方法进行了比较。研究结果表明,人工智能可以增强成像、组织学评估、内窥镜技术和外科手术。渐进式医院实施可显著改变GA的诊断、治疗和预后。
{"title":"AI in the diagnosis and management of gastric adenocarcinoma: A systematic review.","authors":"Ismael Gómez Giménez, Juan Jesús Rubio Garcia, Silvia Carbonell Morote, José Manuel Ramia Ángel","doi":"10.1016/j.cireng.2026.800276","DOIUrl":"10.1016/j.cireng.2026.800276","url":null,"abstract":"<p><p>Gastric cancer (GC) has high mortality due to late diagnosis from nonspecific symptoms. Advances in diagnostics and artificial intelligence (AI) promise earlier detection through greater sensitivity and specificity. This study reviews literature, including meta-analyses and systematic reviews, on AI in gastric adenocarcinoma (GA). In December 2024, following PRISMA, we searched PubMed, Web of Science, and Cochrane. Seventeen of 228 articles met inclusion criteria, comparing AI with other diagnostic or therapeutic approaches. Findings indicate AI may enhance imaging, histological assessment, endoscopy techniques, and surgical procedures. Progressive hospital implementation could significantly transform GA diagnosis, treatment, and prognosis.</p>","PeriodicalId":93935,"journal":{"name":"Cirugia espanola","volume":" ","pages":"800276"},"PeriodicalIF":0.0,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145949532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-08DOI: 10.1016/j.cireng.2026.800278
Jaime López Sánchez, José E Quiñones Sampedro, Pedro A Montalbán Valverde, Luis M González Fernández, Manuel J Iglesias Iglesias, María C Esteban Velasco, Francisco Blanco Antona
Near-infrared fluorescent cholangiography (NIFC) has emerged as a promising technique in laparoscopic cholecystectomy (LC), enabling accurate anatomical identification of the biliary tract. Its use has been associated with improved visualization of critical structures, reduced incidence of complications, lower conversion rates to open surgery, and shorter operative times and hospital stays. Key advantages include its easy integration into routine practice, a short learning curve, and straightforward interpretation of images, provided that appropriate protocols are followed. Nevertheless, several limitations currently hinder its widespread standardization. The absence of high-quality evidence prevents consensus on the optimal indocyanine green dose and timing of administration, while the need for specialized imaging systems restricts universal adoption. Future research should focus on defining uniform protocols, validating their impact on LC outcomes, and consolidating the role of NIFC as an intraoperative reference technique for enhancing safety and efficiency in biliary surgery.
{"title":"Green light for safer biliary surgery: the expanding role of fluorescent cholangiography.","authors":"Jaime López Sánchez, José E Quiñones Sampedro, Pedro A Montalbán Valverde, Luis M González Fernández, Manuel J Iglesias Iglesias, María C Esteban Velasco, Francisco Blanco Antona","doi":"10.1016/j.cireng.2026.800278","DOIUrl":"https://doi.org/10.1016/j.cireng.2026.800278","url":null,"abstract":"<p><p>Near-infrared fluorescent cholangiography (NIFC) has emerged as a promising technique in laparoscopic cholecystectomy (LC), enabling accurate anatomical identification of the biliary tract. Its use has been associated with improved visualization of critical structures, reduced incidence of complications, lower conversion rates to open surgery, and shorter operative times and hospital stays. Key advantages include its easy integration into routine practice, a short learning curve, and straightforward interpretation of images, provided that appropriate protocols are followed. Nevertheless, several limitations currently hinder its widespread standardization. The absence of high-quality evidence prevents consensus on the optimal indocyanine green dose and timing of administration, while the need for specialized imaging systems restricts universal adoption. Future research should focus on defining uniform protocols, validating their impact on LC outcomes, and consolidating the role of NIFC as an intraoperative reference technique for enhancing safety and efficiency in biliary surgery.</p>","PeriodicalId":93935,"journal":{"name":"Cirugia espanola","volume":" ","pages":"800278"},"PeriodicalIF":0.0,"publicationDate":"2026-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145949522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.cireng.2025.800244
Paula Muñoz-Muñoz , Irene López-Rojo , Amaia Ilundain-Idoate , Pedro Bretcha-Boix , Rosa M. Cañon , Felipe A. Calvo , Jose Manuel Asencio-Pascual
Soft tissue sarcomas (STS) require a multidisciplinary approach that balances oncologic control with functional preservation. Adjuvant external beam radiotherapy (EBRT) improves local control but is often limited by its toxicity. Intraoperative radiotherapy (IORT) allows for precise delivery of a single high dose during surgery, minimizing radiation exposure to adjacent tissues. This study reviews the role of IORT to treat sarcoma in the extremities and retroperitoneum, while also evaluating current clinical applications, prognosis and usage trends in Spain, based on a national survey that collected responses from all centers currently using IORT. IORT is employed in STS treatment in 11 Spanish hospitals (mostly electron-based systems), but the volume of patients treated is very low (63.6% use IORT in ≤10 cases per year). Despite favorable local control rates and reduced morbidity, access to IORT remains inconsistent at sarcoma referral centers. Broader integration and standardized protocols are needed, alongside future prospective studies on neoadjuvant EBRT and IORT.
{"title":"“Current Use and Clinical Applications of Intraoperative Radiotherapy in Soft Tissue Sarcomas: Insights from a National Survey in Spain”","authors":"Paula Muñoz-Muñoz , Irene López-Rojo , Amaia Ilundain-Idoate , Pedro Bretcha-Boix , Rosa M. Cañon , Felipe A. Calvo , Jose Manuel Asencio-Pascual","doi":"10.1016/j.cireng.2025.800244","DOIUrl":"10.1016/j.cireng.2025.800244","url":null,"abstract":"<div><div>Soft tissue sarcomas (STS) require a multidisciplinary approach that balances oncologic control with functional preservation. Adjuvant external beam radiotherapy (EBRT) improves local control but is often limited by its toxicity. Intraoperative radiotherapy (IORT) allows for precise delivery of a single high dose during surgery, minimizing radiation exposure to adjacent tissues. This study reviews the role of IORT to treat sarcoma in the extremities and retroperitoneum, while also evaluating current clinical applications, prognosis and usage trends in Spain, based on a national survey that collected responses from all centers currently using IORT. IORT is employed in STS treatment in 11 Spanish hospitals (mostly electron-based systems), but the volume of patients treated is very low (63.6% use IORT in ≤10 cases per year). Despite favorable local control rates and reduced morbidity, access to IORT remains inconsistent at sarcoma referral centers. Broader integration and standardized protocols are needed, alongside future prospective studies on neoadjuvant EBRT and IORT.</div></div>","PeriodicalId":93935,"journal":{"name":"Cirugia espanola","volume":"104 1","pages":"Article 800244"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145472575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.cireng.2025.800248
Rosa M. Jimenez-Rodriguez , Fátima Aguilar-del-Castillo , Felipe Quezada-Diaz , Julio García-Aguilar
Locally advanced rectal cancer has traditionally been treated with neoadjuvant chemoradiotherapy, followed by total mesorectal excision (TME)—a technique that is effective but associated with high morbidity and functional impairment. The identification of patients with a clinical complete response (cCR) after treatment has driven the adoption of the “Watch-and-Wait” (W&W) strategy, aimed at avoiding surgery without compromising oncologic safety. Current evidence, drawn from international series, multicentre records, and clinical trials, supports the view that W&W offers overall survival and disease-free survival rates comparable to those of radical surgery, with clear advantages in organ preservation and quality of life. However, this strategy requires careful patient selection, standardised re-evaluation protocols, and intensive follow-up in specialised centres. In summary, W&W has become a valid and safe alternative to surgical treatment in selected patients with rectal cancer following neoadjuvant therapy.
{"title":"Organ preservation in rectal cancer: Clinical basis of the watch-and-wait strategy","authors":"Rosa M. Jimenez-Rodriguez , Fátima Aguilar-del-Castillo , Felipe Quezada-Diaz , Julio García-Aguilar","doi":"10.1016/j.cireng.2025.800248","DOIUrl":"10.1016/j.cireng.2025.800248","url":null,"abstract":"<div><div>Locally advanced rectal cancer has traditionally been treated with neoadjuvant chemoradiotherapy, followed by total mesorectal excision (TME)—a technique that is effective but associated with high morbidity and functional impairment. The identification of patients with a clinical complete response (cCR) after treatment has driven the adoption of the “Watch-and-Wait” (W&W) strategy, aimed at avoiding surgery without compromising oncologic safety. Current evidence, drawn from international series, multicentre records, and clinical trials, supports the view that W&W offers overall survival and disease-free survival rates comparable to those of radical surgery, with clear advantages in organ preservation and quality of life. However, this strategy requires careful patient selection, standardised re-evaluation protocols, and intensive follow-up in specialised centres. In summary, W&W has become a valid and safe alternative to surgical treatment in selected patients with rectal cancer following neoadjuvant therapy.</div></div>","PeriodicalId":93935,"journal":{"name":"Cirugia espanola","volume":"104 1","pages":"Article 800248"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145589622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.cireng.2025.800262
Corrado P. Marini , Patrizio Petrone , Francesca Izzo , David A. Lieb II , Srinivas H. Reddy , John McNelis
Background
This study assessed whether there is a correlation between the grade of splenic injury and the semiquantitative assessment of the amount of the hemoperitoneum (HP) by a modified Federle score (mFS), and which of the 2 factors is more predictive of the need for intervention in adult patients with isolated blunt splenic injury (iBSI).
Methods
Retrospective cohort study of patients admitted (1/1/2019−12/31/2022) with iBSI. Continuous data are presented as means ± standard deviation and non-parametric data as frequencies with percentages. A test-retest analysis for intra- and inter-class reliability of HP assessment was done in a 10-patient subgroup.
Results
Among the 62 patients, 47 (75.8%) were managed nonoperatively (23 observation, 24 splenic artery embolization [SAE]), and 15 underwent splenectomy. The grade of splenic injury and mFS scores were 3.6 ± 1.3 and 4.1 ± 1.9, respectively. The 22 patients who underwent SAE were more severely injured in terms of grade of splenic injury (4.0 ± 1.2 vs 2.6 ± 1.1), amount of HP by mFS (4.1 ± 1.8 vs 3.1 ± 1.7) and ISS (21 ± 11 vs 15 ± 12) compared to the observed patients (P < .05). Mortality was 8%. SAE and splenectomy groups differed only by the quantity of HP (4.1 ± 1.8 vs 5.5 ± 1.3). While there was a correlation between AAST grade and mFS, only mFS was predictive of splenectomy.
Conclusion
The quantity of HP as assessed by mFS may be more predictive than the grade of splenic injury regarding the need for splenectomy in patients with iBSI.
背景:本研究评估脾脏损伤等级与改良Federle评分(mFS)半定量评估腹腔积血(HP)量之间是否存在相关性,以及这两个因素中哪一个更能预测成人孤立性钝性脾损伤(iBSI)患者是否需要干预。方法:对2019年1月1日至2022年12月31日住院的iBSI患者进行回顾性队列研究。连续数据以平均值±标准差表示,非参数数据以频率和百分比表示。在10例患者亚组中,对HP评估的类内和类间可靠性进行了重测分析。结果:62例患者中,非手术治疗47例(75.8%)(23例观察,24例脾动脉栓塞[SAE]), 15例脾切除术。脾损伤分级和mFS评分分别为3.6±1.3分和4.1±1.9分。与观察的患者相比,22例SAE患者在脾损伤等级(4.0±1.2 vs 2.6±1.1)、mFS HP(4.1±1.8 vs 3.1±1.7)和ISS(21±11 vs 15±12)方面的损伤更严重(P结论:mFS评估的HP数量可能比脾损伤等级更能预测iBSI患者是否需要脾切除术。
{"title":"A modified Federle score is superior to injury grade in predicting the need for splenectomy in patients with isolated blunt splenic trauma","authors":"Corrado P. Marini , Patrizio Petrone , Francesca Izzo , David A. Lieb II , Srinivas H. Reddy , John McNelis","doi":"10.1016/j.cireng.2025.800262","DOIUrl":"10.1016/j.cireng.2025.800262","url":null,"abstract":"<div><h3>Background</h3><div>This study assessed whether there is a correlation between the grade of splenic injury and the semiquantitative assessment of the amount of the hemoperitoneum (HP) by a modified Federle score (mFS), and which of the 2 factors is more predictive of the need for intervention in adult patients with isolated blunt splenic injury (iBSI).</div></div><div><h3>Methods</h3><div>Retrospective cohort study of patients admitted (1/1/2019−12/31/2022) with iBSI. Continuous data are presented as means ± standard deviation and non-parametric data as frequencies with percentages. A test-retest analysis for intra- and inter-class reliability of HP assessment was done in a 10-patient subgroup.</div></div><div><h3>Results</h3><div>Among the 62 patients, 47 (75.8%) were managed nonoperatively (23 observation, 24 splenic artery embolization [SAE]), and 15 underwent splenectomy. The grade of splenic injury and mFS scores were 3.6 ± 1.3 and 4.1 ± 1.9, respectively. The 22 patients who underwent SAE were more severely injured in terms of grade of splenic injury (4.0 ± 1.2 vs 2.6 ± 1.1), amount of HP by mFS (4.1 ± 1.8 vs 3.1 ± 1.7) and ISS (21 ± 11 vs 15 ± 12) compared to the observed patients (<em>P</em> < .05). Mortality was 8%. SAE and splenectomy groups differed only by the quantity of HP (4.1 ± 1.8 vs 5.5 ± 1.3). While there was a correlation between AAST grade and mFS, only mFS was predictive of splenectomy.</div></div><div><h3>Conclusion</h3><div>The quantity of HP as assessed by mFS may be more predictive than the grade of splenic injury regarding the need for splenectomy in patients with iBSI.</div></div>","PeriodicalId":93935,"journal":{"name":"Cirugia espanola","volume":"104 1","pages":"Article 800262"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145598233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}